In this study, we report that MECOM promotes cellular proliferation and migration in ovarian cancer cells harboring MECOM amplification and pinpoint cisplatin resistance as an intrinsic property of MECOM-amplified ovarian cancer cells. Here, MECOM is linked to ovarian cancer.